Company Data

MAIA Biotechnology Inc.

Fundamental Analysis:

MAIA Biotechnology Inc.

MAIA Biotechnology Inc.
Fundamental Analysis:
Current Price
$2.4 2.13%
Market Cap
Price Target
Refer to Report
52wk Range
$2.12 - $9.64
Advanced Market Data


MAIA is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. Our lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. For more information, please visit

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.